Biopharmaceuticals Experience Rapid Growth as Manufacturing becomes Cheaper and Demand for Enzymes Rises.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c50905) has announced the addition of Frost & Sullivan's new report: Biotechnology Up-Stream and Down-Stream Processing Technology Analysis (Technical Insights) to their offering. This research service titled Biotechnology: UpStream and DownStream Processing Downstream processing refers to the recovery and purification of biosynthetic products, particularly pharmaceuticals, from natural sources such as animal or plant tissue or fermentation broth, including the recycling of salvageable components and the proper treatment and disposal Technology Analysis examines the developments in bioprocessing and enabling technologies such as transgenic trans·ge·nic adj. 1. Of, relating to, or being an organism whose genome has been altered by the transfer of a gene or genes from another species or breed: transgenic mice. 2. production of proteins in plants, microorganisms, mammalian cells, and eggs. It also includes an in-depth analysis of new separation technologies for downstream processing and technologies for genetically engineering more potent antibodies and enzymes with higher activity, among others. In this study, expert analysts thoroughly examine both upstream and downstream processing of biotechnology. Market Overview Biopharmaceuticals Experience Rapid Growth as Manufacturing becomes Cheaper and Demand for Enzymes Rises The global market for biopharmaceuticals has been growing at an impressive compound annual growth rate (CAGR CAGR See: Compound Annual Growth Rate ) of approximately 30 percent over the last five years. "Currently, this market is likely to be worth around $50 billion," according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the analyst of this study. "More than 500 products are estimated to be in active clinical trials." Manufacturing can constitute as much as half of a pharmaceutical company's expenses. Due to these expenditures, pharmaceutical companies opt for biotech processing -- both upstream and downstream -- to increase production and reduce costs. Moreover, enzymes currently used in many end-user industries such as agriculture, food processing Food processing is the set of methods and techniques used to transform raw ingredients into food for consumption by humans or animals. The food processing industry utilises these processes. , textiles, detergents, and pharmaceuticals are in demand. This growth in demand is creating opportunities for novel enzymes or their applications. This, in turn, fuels research requirements in bioprocess bi·o·proc·ess n. 1. A technique that produces a biological material, such as a genetically engineered microbial strain, for commercial use. 2. and handling. Soaring Sales of Monoclonal Antibodies This is a list of monoclonal antibodies, antibodies which are clones of a single parent cell. When used as medications, the generic names end in -mab (see "Nomenclature of monoclonal antibodies"). and Advantages of Biocatalysis Over Chemical Synthesis In chemistry, chemical synthesis is purposeful execution of chemical reactions in order to get a product, or several products. This happens by physical and chemical manipulations usually involving one or more reactions. Drive Growth of Biotechnology Monoclonal antibodies (mAbs) represent a primary sector of the biopharmaceuticals market. The specificity of mAbs against antigens has tremendous clinical value, making them effective therapeutic agents. Many large-sized pharmaceutical companies are looking at mAb research more closely after the success of products such as Remicade and Rituxan. Processes for the purification of these antibodies will have a significant impact on a company's bottom line. On another front, biocatalysis provides major advantages over standard chemical syntheses, such as its use in producing chiral chi·ral adj. Of or relating to the structural characteristic of a molecule that makes it impossible to superimpose it on its mirror image. chi·ral compounds with lower production costs than synthetic techniques. This is likely to tilt the biotechnology market in its favor as cost of materials drives the entire pharmaceutical industry. Separation also plays a major role in pharmaceutical product development, due to the need to separate the target molecule resulting from chemical synthesis. "As a result, costs are high because of solvent consumption and lower throughputs in the development stage," notes the analyst. "Separation technologies that are scalable from the analytical stage through to the industrial scale are in demand." Overall, due to various factors in the pharmaceutical industry, biotechnology is likely to be in very high demand. For more information visit http://www.researchandmarkets.com/reports/c50905 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion